Cytokinetics Inc. buy Needham & Company LLC
Start price
04.08.23
/
50%
€30.20
Target price
04.08.24
€54.39
Performance (%)
47.68%
Price
24.05.24
€44.60
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Cytokinetics Inc. has seen massive gains of 47.68%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | -18.909% | -18.909% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€66.32
23.05.25
23.05.25
-0.45%
24.05.24
24.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€59.00
09.05.24
09.05.24
€100.26
09.05.25
09.05.25
-24.41%
24.05.24
24.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
09.04.24
09.04.24
€99.24
09.04.25
09.04.25
-34.41%
24.05.24
24.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€71.00
28.02.24
28.02.24
€99.73
28.02.25
28.02.25
-37.18%
24.05.24
24.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€73.50
27.12.23
27.12.23
€97.23
27.12.24
27.12.24
-39.32%
24.05.24
24.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€31.40
20.10.23
20.10.23
€56.68
20.10.24
20.10.24
41.40%
24.05.24
24.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24